Table 1.
Baseline characteristics of women who became pregnant in ASPIRE*
| Became pregnant during follow-up | Did not become pregnant during follow-up | |||
|---|---|---|---|---|
| Placebo | Dapivirine | Overall | ||
| n=87 | n=82 | N=169 | N=2,367 | |
| Age | 24 (21, 27) | 23 (20, 27) | 23 (21, 27) | 26 (22, 31) |
| Married | 36 (41%) | 29 (35%) | 65 (38%) | 962 (40%) |
| Secondary education or greater | 50 (57%) | 44 (54%) | 94 (56%) | 1,093 (46%) |
| Number of live births | 2 (1, 2) | 1 (1, 2) | 2 (1, 2) | 2 (1, 3) |
| Country: Malawi | 6 (7%) | 3 (4%) | 9 (5%) | 238 (10%) |
| South Africa | 43 (49%) | 47 (57%) | 90 (53%) | 1,293 (54%) |
| Uganda | 12 (14%) | 13 (16%) | 25 (15%) | 221 (9%) |
| Zimbabwe | 26 (30%) | 19 (23%) | 45 (27%) | 630 (26%) |
| Condom used at last sex act | 56 (64%) | 51 (62%) | 107 (64%) | 1,366 (57%) |
| Any curable STI at enrollment1 | 11 (13%) | 24 (29%) | 35 (21%) | 501 (21%) |
*
Data presented as N (%) or median (interquartile range)
1
STI = sexually transmitted infection; this included C. trachomatis, N. gonorroheae, T. vaginalis or syphilis. STIs were treated per local guidelines.